Biomarkers for CNS injury in COVID-19 and relationship to neurological symptoms and disease severity


  • Most patients with coronavirus disease 2019 (COVID-19) had a negative standard cerebrospinal fluid (CSF) workup, but markers or neuronal injury were increased.

Why this matters

    Few studies have investigated CSF in patients with COVID-19; understanding COVID-19 relates to CSF analyses and neuronal injury markers may aid in improving treatment outcomes.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.